Results 201 to 210 of about 30,877,029 (400)
KMT2A degradation is observed in decitabine‐responsive acute lymphoblastic leukemia cells
Molecular Oncology, EarlyView.We demonstrate that decitabine (DEC) not only degrades the DNA methyltransferase DNMT1 but also the leukemic driver lysine methyltransferase KMT2A likely due to structural similarity of the DNA‐binding CXXC domains. DEC influences KMT2A downstream processes and synergizes with menin inhibitor revumenib (REV) to decrease leukemic cell proliferation, and
Luisa Brock +10 more
wiley +1 more source
Retracted: Primary Small Cell Undifferentiated (Neuroendocrine) Carcinoma of the Maxillary Sinus
Case Reports in Dentistry, 2014 Case Reports in Dentistry
doaj +1 more source
Molecular Oncology, EarlyView.CD226+CD8+ T cells express elevated levels of RUNX2, exhibit higher proliferation capacity, cytokines and cytolytic molecules expression, and migratory capacity. In contrast, CD226−CD8+ T cells display an exhausted phenotype associated with the increased expression of co‐inhibitory receptors and impaired effector functions.
Maryam Rezaeifar +4 more
wiley +1 more source
Retracted: Brain Metastasis as an Initial Manifestation of Ovarian Carcinoma: A Case Report
Case Reports in Medicine, 2013 Case Reports in Medicine
doaj +1 more source
A CLINICAL REPORT OF A CASE OF BLASTOMYCOSIS OF THE SKIN FROM ACCIDENTAL INOCULATION. [PDF]
, 1903 N. Evans
openalex +1 more source
Molecular Oncology, EarlyView.Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy +12 more
wiley +1 more source
Bilateral Cystosarcoma Phyllodes, Malignant Variant, with 14-Year Followup A Case Report
, 1958 Theobald Reich, Cyril Solomon
openalex +2 more sources